The comparative efficacy of bivalirudin is markedly attenuated by use of radial access: insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium

摘要

Aim The purpose of our study was to evaluate the relative impact of bivalirudin on bleeding outcomes associated with transradial interventions (TRI) in real world practice.